Hyperloop Capital Insights: Market Movers – Pfizer, Micron, and Nissan Lead the Charge
Pfizer’s strong 2025 outlook boosted its stock, while Micron’s revenue forecast exceeds expectations. Nissan and Honda explore a merger to navigate the EV revolution, and Teva’s IBD drug trial shows promise.
Hyperloop Capital Insights: Market Movers – Pfizer, Micron, and Nissan Lead the Charge Read More »